Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19
| Autor: | Katie P Truong, David R Li, Tina Mosaferi, Pratyaksh K Srivastava, Marcella Calfon Press, Soniya V. Rabadia, Ines Donangelo, Neal M. Dixit, Theodoros Kelesidis |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Endocrinology Diabetes and Metabolism Levothyroxine Myxedema coma 030209 endocrinology & metabolism Case Reports 030204 cardiovascular system & hematology Cardiovascular thyroid 03 medical and health sciences 0302 clinical medicine Internal medicine medicine 2.1 Biological and endogenous factors Aetiology Lung Subacute thyroiditis Cancer business.industry Prevention Glasgow Coma Scale Cardiac arrhythmia COVID-19 Sudden cardiac arrest Pneumonia medicine.disease Pulmonary embolism respiratory tract diseases Coronavirus medicine.anatomical_structure Infectious Diseases Heart Disease Cardiology Pneumonia & Influenza hypothyroidism immunotherapy medicine.symptom business AcademicSubjects/MED00250 medicine.drug |
| Zdroj: | Journal of the Endocrine Society, vol 4, iss 10 Journal of the Endocrine Society |
| Popis: | SARS-CoV-2 infection is associated with significant lung and cardiac morbidity but there is a limited understanding of the endocrine manifestations of coronavirus disease 2019 (COVID-19). Although thyrotoxicosis due to subacute thyroiditis has been reported in COVID-19, it is unknown whether SARS-CoV-2 infection can also lead to decompensated hypothyroidism. We present the first case of myxedema coma (MC) in COVID-19 and we discuss how SARS-CoV-2 may have precipitated multiorgan damage and sudden cardiac arrest in our patient. A 69-year-old woman with a history of small cell lung cancer presented with hypothermia, hypotension, decreased respiratory rate, and a Glasgow Coma Scale score of 5. The patient was intubated and administered vasopressors. Laboratory investigation showed elevated thyrotropin, very low free thyroxine, elevated thyroid peroxidase antibody, and markedly elevated inflammatory markers. SARS-CoV-2 test was positive. Computed tomography showed pulmonary embolism and peripheral ground-glass opacities in the lungs. The patient was diagnosed with myxedema coma with concomitant COVID-19. While treatment with intravenous hydrocortisone and levothyroxine were begun the patient developed a junctional escape rhythm. Eight minutes later, the patient became pulseless and was eventually resuscitated. Echocardiogram following the arrest showed evidence of right heart dysfunction. She died 2 days later of multiorgan failure. This is the first report of SARS-CoV-2 infection with MC. Sudden cardiac arrest likely resulted from the presence of viral pneumonia, cardiac arrhythmia, pulmonary emboli, and MC—all of which were associated with the patient’s SARS-CoV-2 infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|